Rafferty Asset Management Portfolio holdings
AUM
$30.3B
1-Year Return
18.89%
This Quarter Return
+3.34%
1 Year Return
+18.89%
3 Year Return
+101.02%
5 Year Return
+164.75%
10 Year Return
+314.44%
AUM
$5.69B
AUM Growth
-$527M
(-8.5%)
Cap. Flow
-$754M
Cap. Flow
% of AUM
-13.25%
Top 10 Holdings %
Top 10 Hldgs %
44.35%
Holding
882
New
93
Increased
308
Reduced
393
Closed
87
Top Buys
| 1 |
Exxon Mobil
XOM
|
$36.7M |
| 2 |
Chevron
CVX
|
$33M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$25.6M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
$15.9M |
| 5 |
ConocoPhillips
COP
|
$10.8M |
Top Sells
| 1 |
Energy Select Sector SPDR Fund
XLE
|
$266M |
| 2 |
VanEck Gold Miners ETF
GDX
|
$217M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
$103M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
$90.5M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
$84.7M |
Sector Composition
| 1 | Financials | 13.89% |
| 2 | Technology | 9.88% |
| 3 | Healthcare | 7.2% |
| 4 | Energy | 6.87% |
| 5 | Real Estate | 3.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLR
126
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $6.06M | 0.11% |
143,883
+73,597
| +105% | +$3.1M |
|
|
NVTA
127
DELISTED
Invitae Corporation
NVTA
| $6.04M | 0.11% |
257,106
+138,784
| +117% | +$3.26M |
|
128
RTX Corp
RTX
$212B
| $5.96M | 0.1% |
72,733
-24,819
| -25% | -$2.03M |
|
|
XEC
129
DELISTED
CIMAREX ENERGY CO
XEC
| $5.93M | 0.1% |
99,991
+58,424
| +141% | +$3.47M |
|
130
Coterra Energy
CTRA
$18.6B
| $5.86M | 0.1% |
255,219
+118,004
| +86% | +$2.71M |
|
131
APA Corp
APA
$8.39B
| $5.84M | 0.1% |
201,671
+128,521
| +176% | +$3.72M |
|
132
Allstate
ALL
$54.9B
| $5.84M | 0.1% |
57,439
-9,646
| -14% | -$981K |
|
133
AvalonBay Communities
AVB
$27.4B
| $5.73M | 0.1% |
28,198
-3,836
| -12% | -$779K |
|
134
Moody's
MCO
$89.6B
| $5.64M | 0.1% |
28,858
-4,849
| -14% | -$947K |
|
|
GHDX
135
DELISTED
Genomic Health, Inc.
GHDX
| $5.62M | 0.1% |
96,676
+40,643
| +73% | +$2.36M |
|
|
MRO
136
DELISTED
Marathon Oil Corporation
MRO
| $5.59M | 0.1% |
393,364
+249,536
| +173% | +$3.55M |
|
137
Equity Residential
EQR
$25B
| $5.59M | 0.1% |
73,612
-9,948
| -12% | -$755K |
|
138
Matador Resources
MTDR
$6.23B
| $5.58M | 0.1% |
280,602
+130,957
| +88% | +$2.6M |
|
|
IMMU
139
DELISTED
Immunomedics Inc
IMMU
| $5.55M | 0.1% |
400,010
+96,683
| +32% | +$1.34M |
|
140
Ligand Pharmaceuticals
LGND
$3.27B
| $5.52M | 0.1% |
77,516
+2,468
| +3% | +$176K |
|
141
Ultragenyx Pharmaceutical
RARE
$3.01B
| $5.49M | 0.1% |
86,501
+21,478
| +33% | +$1.36M |
|
142
FibroGen
FGEN
$45.7M
| $5.49M | 0.1% |
4,861
+1,246
| +34% | +$1.41M |
|
|
CLVS
143
DELISTED
Clovis Oncology, Inc.
CLVS
| $5.46M | 0.1% |
367,079
+186,542
| +103% | +$2.77M |
|
144
Amicus Therapeutics
FOLD
$2.47B
| $5.44M | 0.1% |
435,605
+79,212
| +22% | +$989K |
|
|
MRTX
145
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.4M | 0.1% |
52,453
-19,043
| -27% | -$1.96M |
|
146
Acadia Pharmaceuticals
ACAD
$4.3B
| $5.38M | 0.09% |
201,255
+8,735
| +5% | +$234K |
|
147
Exelixis
EXEL
$10.1B
| $5.36M | 0.09% |
250,969
+35,719
| +17% | +$763K |
|
|
BLUE
148
DELISTED
bluebird bio
BLUE
| $5.35M | 0.09% |
3,244
+486
| +18% | +$801K |
|
149
Exact Sciences
EXAS
$9.73B
| $5.34M | 0.09% |
45,260
-12,830
| -22% | -$1.51M |
|
150
Range Resources
RRC
$8.32B
| $5.33M | 0.09% |
764,213
+477,415
| +166% | +$3.33M |
|